The actual start of the regional center for vaccine distribution in Abu Dhabi

The Health Department – Abu Dhabi, the organizational authority for the health care sector in the emirate, announced the actual start of the Regional Center for Vaccine Distribution in Abu Dhabi, after the arrival of the first shipments to the new facility in Abu Dhabi.

This achievement represents a strategic step in the emirate’s march towards consolidating its position as a pivotal center in health supply chains and promoting regional and global health security.

The center is located in the Kizad region, and is occupied by the company “Rafid”, which is affiliated with the “Burelith Group”. It was developed in partnership with the department, the Abu Dhabi Investment Office, GSK International, Abu Dhabi Ports Group, Al Ittihad Shipping, and the Kizad Group.

The center is an essential pillar within the growing life science system in the emirate, as it aims to improve access to vaccines in the region, by taking advantage of the strategic geographical location of Abu Dhabi, and its advanced infrastructure in the field of cooling chains, as well as a flexible organizational environment for innovation.

The launch of the center’s operational operations came as a culmination of a strategic agreement signed between the department and the GSK company during the Abu Dhabi International Health Care Week 2024 to establish a regional distribution center in the emirate.

With this, Abu Dhabi becomes the headquarters of the center of vaccine distribution of GSK in the Middle East, and the fourth globally, which reflects the growing global confidence in the emirate’s capabilities to support health security and vital supply chains.

The achievement also represents one of the first main operational stations within the HELM framework, (Abu Dhabi Life Sciences Complex), which was officially launched last April during the Abu Dhabi International Health Week, and Helm is a strategic platform aimed at attracting investments in life sciences and strengthening partnerships between the public and private sectors and academic circles, which supports Abu Dhabi’s vision to be a leading global partner in the fields of medicine Flour, medicine industry, and logistics vital products.

The department’s agent, Dr. Noura Khamis Al -Ghaithi, said: “The actual operation of the regional vaccine distribution center in Abu Dhabi represents a turning point in our career towards building a comprehensive proactive health model, as we contribute to enhancing the region’s readiness to respond with efficiency and flexibility, and accelerate access to health solutions that create a tangible difference in people’s lives, strengthening Abu Dhabi’s position as a global center Reliable to innovate in life sciences. ”

The center will manage a portfolio that includes more than 20 vaccines, which includes children and adults, which contributes to supporting fortification plans and long health life in the region, as it is characterized by a flexible design that allows it to expand in the future to accommodate new vaccine technologies and meet the increasing demand, while maintaining the highest international standards in quality and safety.

The center is occupied through advanced systems of cooling chains and smart distribution, which ensures preserving the quality of vaccines and following them accurately along the supply chain. The center is also linked to the Federation of Federation of shipping, and covers more than 100 global destinations and provides accurate shipping services for pharmaceutical products subject to special temperatures.

The center is expected to distribute millions of doses annually, while reducing the delivery periods and improving the reliability of the supply chain across the region.